ArticleBrain & spine2025
Early post-operative hydrocephalus following retrosigmoid vestibular schwannoma resection: Incidence, clinical patterns, and outcomes.
Article in Brain & spine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early post-operative hydrocephalus after retrosigmoid vestibular schwannoma (VS) resection is recognised but insufficiently characterised. Research question: What are the incidence, clinical phenotypes, peri-operative predictors, and outcomes of early post-operative hydrocephalus? Material and methods: We retrospectively reviewed 116 consecutive adults who underwent primary retrosigmoid VS removal between 2020 and 2024. Pre-, intra-, and early post-operative variables were correlated with symptomatic hydrocephalus, defined as ventriculomegaly plus neurological decline within four post-operative days. Management, length of stay (LOS), and late CSF-diversion requirements were analysed. Results: Symptomatic hydrocephalus occurred in eight patients (6.9 %) and required external ventricular drainage (EVD) in six (5.2 %). Two reproducible phenotypes were observed: an acute course (n = 2) with abrupt Glasgow Coma Scale (GCS) < 12, driven by tumour-bed hematoma or fulminant cerebellar edema; EVD was maintained for 11-14 days, one patient died, the other needed a ventriculoperitoneal shunt; a mild course (n = 6) with GCS 13-14 and ipsilateral cerebellar edema; four patients required 5-day EVD, all recovered fully. Tumour-bed hematoma was the only significant predictor ( Discussion and conclusion: Early post-operative hydrocephalus complicates 5 % of retrosigmoid VS resections and manifests as either a life-threatening acute form or a mild form. Vigilant early MRI/CT and a stepwise escalation from steroids to selective EVD achieve favourable outcomes; preventing tumour-bed hematoma is the principal modifiable risk factor.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.